DK1210105T3 - Højdensitetslipoprotein mod organdysfunktion som følge af hæmorrhagisk chok - Google Patents

Højdensitetslipoprotein mod organdysfunktion som følge af hæmorrhagisk chok

Info

Publication number
DK1210105T3
DK1210105T3 DK00956651T DK00956651T DK1210105T3 DK 1210105 T3 DK1210105 T3 DK 1210105T3 DK 00956651 T DK00956651 T DK 00956651T DK 00956651 T DK00956651 T DK 00956651T DK 1210105 T3 DK1210105 T3 DK 1210105T3
Authority
DK
Denmark
Prior art keywords
density lipoprotein
organ dysfunction
hemorrhagic shock
dysfunction due
against organ
Prior art date
Application number
DK00956651T
Other languages
Danish (da)
English (en)
Inventor
Gillian Cockerill
Norman Miller
Michelle Macdonald
Christoph Thiemermann
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of DK1210105T3 publication Critical patent/DK1210105T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK00956651T 1999-08-19 2000-08-16 Højdensitetslipoprotein mod organdysfunktion som følge af hæmorrhagisk chok DK1210105T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919713.9A GB9919713D0 (en) 1999-08-19 1999-08-19 New medical use of high density lipoprotein
PCT/GB2000/003182 WO2001013939A1 (en) 1999-08-19 2000-08-16 High density lipoprotein against organ dysfunction following haemorrhagic shock

Publications (1)

Publication Number Publication Date
DK1210105T3 true DK1210105T3 (da) 2004-03-22

Family

ID=10859485

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00956651T DK1210105T3 (da) 1999-08-19 2000-08-16 Højdensitetslipoprotein mod organdysfunktion som følge af hæmorrhagisk chok

Country Status (10)

Country Link
US (1) US6998388B1 (de)
EP (2) EP1369124B1 (de)
AT (2) ATE253931T1 (de)
AU (1) AU779578B2 (de)
CA (1) CA2376260C (de)
DE (2) DE60006548T2 (de)
DK (1) DK1210105T3 (de)
ES (2) ES2209961T3 (de)
GB (1) GB9919713D0 (de)
WO (1) WO2001013939A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035352A1 (de) 2000-07-20 2002-01-31 Zlb Bioplasma Ag Bern Verfahren zur Behandlung von instabiler Angina pectoris
US20040266660A1 (en) * 2001-08-20 2004-12-30 Alphonse Hubsch Hdl for the treatment of stroke and other ischemic conditions
EP1285662A1 (de) * 2001-08-20 2003-02-26 ZLB Bioplasma AG Rekonstituiertes High-Density -Lipoprotein zur Behandlung von Schlaganfällen und Ischämiezuständen
WO2005068020A1 (en) * 2004-01-02 2005-07-28 Advanced Cardiovascular Systems, Inc. High-density lipoprotein coated medical devices
US7759315B2 (en) * 2005-03-09 2010-07-20 Csl Behring Ag Treatment of inflammatory conditions of the intestine
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7956035B2 (en) 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
WO2010057203A2 (en) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Hdl particles for delivery of nucleic acids
DK2767546T3 (en) 2011-02-07 2019-02-04 Cerenis Therapeutics Holding Sa Lipoprotein complexes and their preparation and uses
KR20170003611A (ko) 2014-05-02 2017-01-09 세레니스 쎄라퓨틱스 홀딩 에스에이 Ｈｄｌ 요법 마커
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08198406A (ja) 1995-01-20 1996-08-06 Hitachi Ltd 自動倉庫設備
CA2229140A1 (en) * 1995-08-17 1997-02-27 Protein Design Labs, Inc. Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
JPH1025248A (ja) * 1996-07-08 1998-01-27 Chemo Sero Therapeut Res Inst 抗血管リモデリング剤

Also Published As

Publication number Publication date
ES2307869T3 (es) 2008-12-01
ES2209961T3 (es) 2004-07-01
DE60006548D1 (de) 2003-12-18
EP1369124B1 (de) 2008-06-04
ATE397454T1 (de) 2008-06-15
AU779578B2 (en) 2005-01-27
ATE253931T1 (de) 2003-11-15
GB9919713D0 (en) 1999-10-20
CA2376260A1 (en) 2001-03-01
AU6852500A (en) 2001-03-19
EP1369124A1 (de) 2003-12-10
EP1210105B1 (de) 2003-11-12
CA2376260C (en) 2010-09-28
WO2001013939A1 (en) 2001-03-01
DE60039130D1 (de) 2008-07-17
EP1210105A1 (de) 2002-06-05
DE60006548T2 (de) 2004-09-23
US6998388B1 (en) 2006-02-14

Similar Documents

Publication Publication Date Title
ATE492525T1 (de) Phenyl-benzyl-ketone
DE60039291D1 (de) Camptothecinanaloge und deren zubereitungsmethoden
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
BG104779A (en) Inhibitors of phospholipase enzymes
DK1210105T3 (da) Højdensitetslipoprotein mod organdysfunktion som følge af hæmorrhagisk chok
PT1202724E (pt) Metodo para tratamento da dor cronica utilizando inibidores mek
CY1110664T1 (el) Ενδορινικες συνθεσετς
NO2010006I2 (no) Saksagliptin og farmasøytisk akseptable salter derav, inklusive saksagliptin hydroklorid
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
NO20033440L (no) Behandling av neurologisk dysfunksjon innbefattende fruktopyranosesulfamater og erytropoietin
CY1105371T1 (el) Νευροπροστατευτικα 7-βητα-υδροξυστepοειδη
HRPK20030734B3 (en) A combination comprising combretastatin and anticancer agents
RS54185B1 (en) USE OF 24-ORDER
ATE356143T1 (de) Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
ITGE980093A0 (it) Tenditore del tipo a nottolino di arresto senza gioco.
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
ATE350064T1 (de) Pharmazeutische zusammensetzungen von rapamycines
FI20002452A (fi) Menetelmät hammashoitokoneen vesilinjojen desinfioimiseksi ja hammashoitokoneen vesilinjojen desinfiointijärjestelyt
BG106922A (en) Heterocyclic amide derivatives
EP1539132A4 (de) Verwendung von 2,3 alkylcarbonyloxybenzosäuren, ihre derivate und analoga bei der behandlung von gewebe- und zellfunktionsschäden und verletzungen in säugetieren
DK1239861T3 (da) Kombinationaf cyamemazin og et atypisk neuroleptikum
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
AR028458A1 (es) Un estuche de combinacion usado en el tratamiento del paludismo